In silico BRCA1 pathway analysis in breast invasive carcinoma

Recent developments in clinical patient-based personalized genomics explored a variety of biomarkers for diagnosis, prognosis, and therapy in breast invasive carcinoma (BRIC). BRCA1 mutations mediated a catastrophic situation for a damage-repairing apparatus that induced malignant transformation of...

Full description

Bibliographic Details
Main Authors: Zafar Abbas Shah, Faisal Nouroz, Asima Tayyeb
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:MGM Journal of Medical Sciences
Subjects:
Online Access:http://www.mgmjms.com/article.asp?issn=2347-7946;year=2021;volume=8;issue=1;spage=44;epage=51;aulast=Shah